A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies
暂无分享,去创建一个
P. LoRusso | D. Tan | S. Kaye | P. Schöffski | V. Moreno | D. Olmos | J. Mateo | S. Sandhu | H. Dumez | S. Barr | N. Samberg | S. Poondru | J. V. Van Tornout | Fei Jie | Jan M Van Tornout